Join
Live feed
·
PRReleasevia Quantisnow
Avita Medical Inc. logo

AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes

ByQuantisnow·Wall Street's wire, on your screen.
RCEL· Avita Medical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RCEL (Avita Medical Inc.) and more on Quantisnow.